Vasogen-- VAS on TSE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Vasogen-- VAS on TSE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: stevie who wrote (68)	12/15/1997 9:07:00 PM
From: Rajiv Arya	Read Replies (2) of 377

Re: Conference call. Quite positive overall. Briefy, the key points include: (i) 'final' regulatory approval from Europe expected before end of year; (ii) following final approval, marketing of VasoCare therapy to begin in UK in early '98 through the centres of excellence at which research is currently being conducted; (iii) the president was reluctant to give revenue projections for the first year, but believes them to be in the seven figure range; (iv) discussions currently underway with several potential industry partners for both marketing of therapy and to fund ongoing research, with a definitve agreement to be signed sometime in fiscal '98; (v) these potential partners have showed strong interest in Vasocare's current and future potential indications; (vi) U.S. clinical trials to begin by the 2nd quarter of 98 through prominent centre of excellence; (vii) the company is rather disappointed at the weak market and press reception to the latest news, but believes this will change once the market sees revenues and realizes the full implications of Vasocare. Rajiv

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next